Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Gehring

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|April 17, 2016
The role of innate immunity in the immunopathology and treatment of HBV infectionMala K Maini, Adam J Gehring
Journal of Hepatology|August 15, 2022
Intrahepatic T cells with NK-like properties: Expanding the repertoire of lymphocytes sensitive to bystander activationAdam J Gehring, Sonya A MacParland
Antiviral Research|May 11, 2020
Mechanisms of HBV immune evasionAdrian Kuipery, Adam J Gehring, Masanori Isogawa
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B PatientsConan Chua, Mireia García-López, Adam J Gehring
Expert Review of Anti-Infective Therapy|August 28, 2013
How further suppression of virus replication could improve current HBV treatmentJohn E Tavis, Adam J Gehring, Yuan Hu
Hepatology (Baltimore, Md.)|April 1, 2025
Getting to HBV Cure - will new biomarkers help?Jordan J Feld, Adam J Gehring, Fabien Zoulim
Viruses|October 14, 2011
HBV-Specific Adaptive ImmunityAntonio Bertoletti, Anthony T Tan, Adam J Gehring
Gastroenterology|September 1, 2020
Nucleic Acid Polymer Therapy for Hepatitis B Virus: Strong Hepatitis B Surface Antigen Decline But Many Unanswered QuestionsMilan J Sonneveld, Adam J Gehring, Harry L A Janssen
Gastroenterology|July 22, 2020
ReplyK Seng Liem, Adam J Gehring, Harry L A Janssen
Viruses|April 3, 2021
RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure StrategiesChristine I Wooddell, Adam J Gehring, Man-Fung Yuen, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|April 17, 2016
The role of innate immunity in the immunopathology and treatment of HBV infectionMala K Maini, Adam J Gehring
Journal of Hepatology|August 15, 2022
Intrahepatic T cells with NK-like properties: Expanding the repertoire of lymphocytes sensitive to bystander activationAdam J Gehring, Sonya A MacParland
Antiviral Research|May 11, 2020
Mechanisms of HBV immune evasionAdrian Kuipery, Adam J Gehring, Masanori Isogawa
Methods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B PatientsConan Chua, Mireia García-López, Adam J Gehring
Expert Review of Anti-Infective Therapy|August 28, 2013
How further suppression of virus replication could improve current HBV treatmentJohn E Tavis, Adam J Gehring, Yuan Hu
Hepatology (Baltimore, Md.)|April 1, 2025
Getting to HBV Cure - will new biomarkers help?Jordan J Feld, Adam J Gehring, Fabien Zoulim
Viruses|October 14, 2011
HBV-Specific Adaptive ImmunityAntonio Bertoletti, Anthony T Tan, Adam J Gehring
Gastroenterology|September 1, 2020
Nucleic Acid Polymer Therapy for Hepatitis B Virus: Strong Hepatitis B Surface Antigen Decline But Many Unanswered QuestionsMilan J Sonneveld, Adam J Gehring, Harry L A Janssen
Gastroenterology|July 22, 2020
ReplyK Seng Liem, Adam J Gehring, Harry L A Janssen
Viruses|April 3, 2021
RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure StrategiesChristine I Wooddell, Adam J Gehring, Man-Fung Yuen, et al.
Pageof 9